Skip to main content

Company

Alterity Therapeutics Ltd

ASX:ATH

Alterity Therapeutics is a late-clinical stage biotechnology company dedicated to developing treatments for people living with neurodegenerative diseases. The company is initially focused on developing disease modifying therapies in Parkinson’s disease and related disorders.

1 story